Bioneer A/S

Bioneer A/S is a long-established, private Danish contract research and development organization (CRO/CDMO) serving the biotech and pharmaceutical industries. The company leverages its expertise in cell model and assay development, alongside drug candidate formulation and recombinant protein services, to support client drug discovery and development programs. Its strategic R&D programs are focused on creating 'best-in-class' solutions in high-need areas like CNS, cancer, and immunology. Bioneer operates as a service and platform provider, generating revenue through collaborative R&D and fee-for-service work.

Integrated suite of capabilities in advanced cell model/assay development (focus on CNS, cancer, immunology) and drug candidate development/formulation (recombinant proteins, peptides, small molecules, cell therapies).

Operates in the crowded global CRO/CDMO market, competing with large players like LabCorp, IQVIA, and Lonza, as well as numerous niche specialists. Differentiation is based on deep expertise in specific complex model systems (e.g., neuronal MEA, alpha-synuclein fibrils) and integrated recombinant protein services from R&D to manufacturing.